| Name | 2-[(4-methylthiazol-2-yl)amino]-2-oxo-acetic acid |
|---|---|
| Synonyms |
4-Methyl-tetrahydro-furan-3-ol
3-FURANOL,TETRAHYDRO-4-METHYL 4-Methyltetrahydro-3-furanol (3S,4R)-4-methyloxolan-3-ol 4-methylthiazol-2-ylcarbamoylcarboxylic acid |
| Density | 1.603g/cm3 |
|---|---|
| Molecular Formula | C6H6N2O3S |
| Molecular Weight | 186.18800 |
| Exact Mass | 186.01000 |
| PSA | 107.53000 |
| LogP | 0.54760 |
| Index of Refraction | 1.67 |
| HS Code | 2934100090 |
|---|
|
~%
82514-68-9 |
| Literature: Pfizer Inc. Patent: US4321372 A1, 1982 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |